Mien Chi Chen, MD
Otolaryngology · Seattle, WANPI 1407822679
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,311 of the $3,233 with a category attached, or 71.5%. 7 manufacturers reported payments, led by Intersect ENT, Inc. at 54.9% of the total. Reporting peaked in 2019 at $2,980 and has fallen 99.1% since, to $26 in 2025.
Across 14 payments — averaging $230.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$2K
- Medical Device Business Services, Inc.$1K
- Stryker$142
- Medtronic$61
- Aerin Medical Inc.$46
- Acclarent, Inc$36
- plus $26 from 1 others
What the payments were for
- Travel & lodging$2,31171%
- Food & beverage$92229%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 7 | $1,775 |
| Medical Device Business Services, Inc. | 1 | $1,147 |
| Stryker | 1 | $142 |
| Medtronic | 1 | $61 |
| Aerin Medical Inc. | 2 | $46 |
| Acclarent, Inc | 1 | $36 |
| GSK | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SINUVA$1,775
- PROPEL$1,656
- ENTELLUS - XPRESS ENT DILATION SYSTEM$142
How this compares
$3,233 in reported general payments places this provider in the 85th percentile of 254 otolaryngology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 120 | $3,594 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 12 | $1,521 |
| CefuroximeCefuroxime Axetil | 50 | $1,256 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 17 | $969 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 53 | $784 |
| Ipratropium Bromide | 13 | $313 |
| Methylprednisolone | 29 | $270 |
| Fluticasone Propionate | 12 | $253 |
| Mupirocin | 28 | $252 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $94 |
| Ondansetron OdtOndansetron | 14 | $82 |
| Prednisone | 11 | $48 |
| Amoxicillin | 14 | $44 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Seattle
- Ian HumphreysSeattle$43K
- Craig MillerSeattle$24K
- Sachin GuptaSeattle$23K
- Sharon CushingSeattle$19K
- Albert MeratiSeattle$9K
- Alexander ChiuSeattle$9K
- Lucy ShiSeattle$4K
- Zain RizviSeattle$4K
- Rocco FerrandinoSeattle$3K
- Cole RodmanSeattle$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.